Evidence map›Paper›PMID 30982660›Full record

ArticleDevelopmental cell2019

Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity.

Arash Latifkar, Lu Ling, Amrit Hingorani, Eric Johansen, Amdiel Clement, Xiaoyu Zhang, John Hartman, Claudia Fischbach, Hening Lin, Richard A Cerione and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Developmental cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 152 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Histone acetylation modulators in breast cancer.Breast cancer research : BCR · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Response of MDA-MB231 cells to cisplatin and paclitaxel - viability, migration and gene expression estimation in mono- and co-culture with macrophages.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2025
    Article
  19. Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Arash LatifkarDepartment of Molecular Medicine, Cornell University, Ithaca, NY 14853, USA; Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA.
Lu LingNancy E. and Peter C. Meinig School of Biomedical Engineering, Ithaca, NY 14853, USA; Kavli Institute at Cornell for Nanoscale Science Cornell University, Ithaca, NY 14853, USA.
Amrit HingoraniDepartment of Molecular Medicine, Cornell University, Ithaca, NY 14853, USA.
Eric JohansenDepartment of Molecular Medicine, Cornell University, Ithaca, NY 14853, USA.
Amdiel ClementDepartment of Molecular Medicine, Cornell University, Ithaca, NY 14853, USA.
Xiaoyu ZhangDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA.
John HartmanSibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY 14853, USA.
Claudia FischbachNancy E. and Peter C. Meinig School of Biomedical Engineering, Ithaca, NY 14853, USA; Kavli Institute at Cornell for Nanoscale Science Cornell University, Ithaca, NY 14853, USA.
Hening LinDepartment of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA; Howard Hughes Medical Institute, Cornell University, Ithaca, NY 14853, USA.
Richard A CerioneDepartment of Molecular Medicine, Cornell University, Ithaca, NY 14853, USA; Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA. Electronic address: rac1@cornell.edu.
Marc A AntonyakDepartment of Molecular Medicine, Cornell University, Ithaca, NY 14853, USA.
Cornell University · USIthaca College · US

Funding

Training and OutreachP30GM124166 · NIGMS · CORNELL UNIVERSITY · PI RICHARD A. CERIONE · 2019 to 2026
$28.3M
Project 3: Physical and Metabolic Constraints of Cancer Cell InvasionU54CA210184 · NCI · CORNELL UNIVERSITY · PI SCHAFFER, CHRIS B · 2016 to 2020
$10.2M
The unique roles of the GTP-binding/protein crosslinking enzyme transglutaminase-2 and signaling partners in aggressive cancersR01CA201402 · NCI · CORNELL UNIVERSITY · PI CERIONE, RICHARD A. · 2016 to 2024
$4.3M
New frontiers in extracellular signalingR35GM122575 · NIGMS · CORNELL UNIVERSITY · PI CERIONE, RICHARD A. · 2017 to 2021
$3.0M
The role of lysosomal deregulation in cancer progressionF99CA234921 · NCI · CORNELL UNIVERSITY · PI LATIFKAR, ARASH · 2018 to 2019
$84k
NCI NIH HHS F99 CA234921NCI NIH HHS R01 CA201402NCI NIH HHS U54 CA210184NIGMS NIH HHS P30 GM124166NIGMS NIH HHS R35 GM122575
6 · The paper itself

Abstract

The NAD

Indexed as

Breast NeoplasmsCell Line, TumorCell SurvivalExosomesFemaleHomeostasisHumansLysosomesMultivesicular BodiesNeoplasm InvasivenessSirtuin 1Vacuolar Proton-Translocating ATPasesSIRT1 protein, humanSirtuin 1Vacuolar Proton-Translocating ATPasescancercathepsindeacetylationexosomesextracellular vesicleslysosomemulti-vesicular bodysecretomesirtuinvacuolar-type H(+) ATPase

Identifiers

PMID30982660
PMCPMC6519475
OpenAlexW2938250883

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.